Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver disease that can progress to end-stage conditions with life-threatening complications, but no pharmacologic therapy has been approved
It may offer benefits, especially in aesthetic and anti-aging protocols, but risks demand careful dosing, monitoring, and a full patient-informed consent process
doi: 10.2337/diabetes.50.3.609 91 NauckMStckmannFEbertRCreutzfeldtW
For C max , the comparison between 1 mg/mL and 3 mg/mL met the equivalence criterion but equivalence was not shown for 1 mg/mL relative to 10 mg/mL or for 3 mg/mL relative to 10 mg/mL, as C max increased with increasing strength
Back Randle, PJ (29 May 1954) 'Assay of plasma insulin activity by the rat-diaphragm method', British Medical Journal , 1, 1237-40